EP3583404A1 - Verfahren und anordnung zum kalibrieren von vorrichtungen zur erkennung von blut oder blutbestandteilen in einer flüssigkeit - Google Patents

Verfahren und anordnung zum kalibrieren von vorrichtungen zur erkennung von blut oder blutbestandteilen in einer flüssigkeit

Info

Publication number
EP3583404A1
EP3583404A1 EP18710329.6A EP18710329A EP3583404A1 EP 3583404 A1 EP3583404 A1 EP 3583404A1 EP 18710329 A EP18710329 A EP 18710329A EP 3583404 A1 EP3583404 A1 EP 3583404A1
Authority
EP
European Patent Office
Prior art keywords
blood
light
scattering
cuvette
standard
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18710329.6A
Other languages
German (de)
English (en)
French (fr)
Inventor
Andreas Röse
Sylvia Heinitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Medical Care Deutschland GmbH
Original Assignee
Fresenius Medical Care Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Medical Care Deutschland GmbH filed Critical Fresenius Medical Care Deutschland GmbH
Publication of EP3583404A1 publication Critical patent/EP3583404A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/27Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
    • G01N21/274Calibration, base line adjustment, drift correction
    • G01N21/278Constitution of standards
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1692Detection of blood traces in dialysate
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/42Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
    • B01D61/422Electrodialysis
    • B01D61/423Electrodialysis comprising multiple electrodialysis steps
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01DMEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D18/00Testing or calibrating apparatus or arrangements provided for in groups G01D1/00 - G01D15/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01JMEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/02Details
    • G01J3/0275Details making use of sensor-related data, e.g. for identification of sensor parts or optical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01JMEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/02Details
    • G01J3/0291Housings; Spectrometer accessories; Spatial arrangement of elements, e.g. folded path arrangements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01JMEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/02Details
    • G01J3/10Arrangements of light sources specially adapted for spectrometry or colorimetry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/27Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
    • G01N21/274Calibration, base line adjustment, drift correction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84Systems specially adapted for particular applications
    • G01N21/88Investigating the presence of flaws or contamination
    • G01N21/93Detection standards; Calibrating baseline adjustment, drift correction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3639Blood pressure control, pressure transducers specially adapted therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/15Detection of leaks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3306Optical measuring means
    • A61M2205/3313Optical measuring means used specific wavelengths
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/70General characteristics of the apparatus with testing or calibration facilities
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/27Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
    • G01N21/274Calibration, base line adjustment, drift correction
    • G01N21/276Calibration, base line adjustment, drift correction with alternation of sample and standard in optical path

Definitions

  • the invention relates to a method and an arrangement for calibrating
  • Devices for detecting blood or blood constituents in a liquid, in particular dialysis fluid which have a light emitter and a light receiver and an evaluation unit receiving the signal of the light receiver, which is designed such that blood or blood constituents in the fluid based on the weakening of one through the Liquid passing radiation can be detected.
  • devices are used to protect the patient, with which the in the event of rupture of the membrane of the dialyzer can not be reliably excluded entry of blood into the dialysis fluid can be detected. These devices are also referred to as blood leak detectors.
  • the apparatus includes a light receiver for receiving the light passing through the liquid and an evaluation unit configured to close the presence of blood or a blood component in the liquid based on the difference in absorption of the light in the two wavelength ranges becomes.
  • the known devices for detecting blood or blood components must be calibrated after production. First, there is a zero balance with a
  • Dialysis fluid or RO water instead.
  • a cuvette filled with dialysis fluid or RO water is interposed in the beam path of the blood leak detector
  • the invention has for its object to provide a simplified method for calibrating devices for detecting blood or blood components in a liquid, in particular dialysis fluid.
  • an object of the invention is an arrangement for calibrating devices for detecting blood or blood constituents in a liquid, in particular dialysis fluid,
  • the method according to the invention is based on the fact that the calibration of the devices for the detection of blood or blood components is based on the use of blood, whereby the method is greatly simplified.
  • the calibration is not carried out with a calibration solution containing blood, but with two different calibration standards that take into account the special optical properties of blood.
  • the calibration is performed with a Absorption standard, which has given in relation to the absorption of light in blood predetermined optical properties, wherein the absorption standard is arranged in the beam path between the light emitter and the light receiver.
  • the absorption standard allows the detection of a defined spectral attenuation of the light as a function of the constituents of the blood, in particular hemoglobin.
  • the beam path of the device for detecting blood can be selectively influenced in order to be able to check whether the light receiver or the evaluation unit is capable of recognizing and correctly interpreting the spectral attenuation.
  • the absorption standard does not cause any scattering, as a result of which a differentiation of the beam path from blood is produced. Consequently, the absorption standard can not be considered a blood substitute.
  • the calibration is performed not only with an absorption standard, but also with a scattering standard that has predetermined optical properties with respect to the scattering of the light in blood.
  • the scattering standard like the absorption standard, is arranged in the beam path between the light transmitter and the light receiver.
  • the absorption standard and the stray normal do not contain any blood, there is no problem of costly procurement measures and temporal instability.
  • the calibration can be done at any time with the blood-free absorption standard and stray normal, which are easy to handle.
  • the given optical properties of the absorption standard and stray normal should be the optical properties of the blood, in particular human blood, in view of correspond to the absorption of light or with respect to the scattering of light. But for the calibration it is not necessary that the optical properties of the blood, in particular human blood, in view of correspond to the absorption of light or with respect to the scattering of light. But for the calibration it is not necessary that the optical properties of the blood, in particular human blood, in view of correspond to the absorption of light or with respect to the scattering of light. But for the calibration it is not necessary that the optical properties of the
  • Absorption standard and stray normal with those of the blood are identical, but in practice it is sufficient if the absorption standard and stray normal have similar optical properties. If the devices to be calibrated for the detection of blood differ on the evaluation of the different absorption of light
  • Absorption standard and the stray normal correspond to the optical properties of blood at least in the wavelength ranges concerned.
  • the transmission spectrum of the absorption standard should be at least two
  • Wavelength ranges correspond to the transmission spectrum of blood, with one wavelength range between 550 nm and 575 nm and the other wavelength range between 630 to 780 nm.
  • the optical properties in terms of absorption and scattering the optical
  • Measurement methods are determined and then checked to see whether they agree with those of the blood sufficiently.
  • the spectral distribution of the light of the light transmitter exerts an influence on the accuracy of the detection of blood.
  • the method according to the invention therefore provides for a measurement of the spectral distribution of the light of the light transmitter.
  • Wavelength ranges before.
  • a calibration data set describing the characteristic properties of the device for detecting blood or blood constituents is preferably determined.
  • the calibration record may contain, for example, correction data that are taken into account in the evaluation of the signal of the light receiver.
  • the correction data can be, for example, correction factors.
  • the calibration record can also be the spectral distribution of the light of the light sender descriptive data receive.
  • the calibration record contains further data for identifying the calibrated device for detecting blood or blood components, so that the determined calibration data sets can be assigned to the individual devices for detecting blood.
  • the determined calibration data records are preferably stored in a memory of
  • the identification data may be, for example, a serial number or a MAC address.
  • the absorption standard comprises an absorption body, which preferably has two parallel surfaces, so that the light can enter the one surface and exit from the other surface.
  • the use of a plane-parallel color filter requires an exact positioning and alignment in the beam path, which can be achieved by suitable design measures, for example by a suitable filter holder.
  • Absorbent body is a transparent potting compound, in which a dye is embedded. Since the color particles are enclosed in a potting compound, a stable and homogeneous distribution of the color particles can be achieved.
  • the embedding of the dye in the potting compound allows the reproducible production of an absorbent body with predetermined optical properties, which is characterized by a high long-term stability.
  • PMMA polymethyl methacrylate
  • the dye is dissolved in a liquid potting compound, in particular PMMA, and the solution is cured in the form of a body having two parallel surfaces, for example in the form of a flat round or rectangular disk.
  • a liquid potting compound in particular PMMA
  • the solution is cured in the form of a body having two parallel surfaces, for example in the form of a flat round or rectangular disk.
  • the surfaces of the absorbent body may be treated by suitable methods, for example, ground or polished to achieve smooth surfaces.
  • the optical properties of the dye should substantially match the optical properties of the blood.
  • the transmission spectrum of the dye should correspond to the transmission spectrum of blood, at least for the wavelength ranges used, in particular two wavelength ranges, one lying between 550 nm and 575 nm and the other between 630 and 780 nm.
  • ROTVIOLETT R known dye of the company Lanxess Germany GmbH is particularly suitable.
  • the transmission spectrum of this dye is not with the
  • a further preferred embodiment of the absorption standard provides that the transparent potting compound is cast between two parallel glass plates, whereby an optically homogeneous light path through the glass plates and the potting compound is formed.
  • a particularly preferred embodiment of the absorption standard has a cuvette filled with a liquid, in which the absorption body is arranged.
  • the cuvette is preferably a glass cuvette, in particular a cylindrical glass cuvette.
  • the cuvette can be filled with dialysis fluid, which is characterized by optical
  • a particularly preferred embodiment provides a filling with water that has been treated with a reverse osmotic cleaning method (RO water).
  • RO water reverse osmotic cleaning method
  • PEG polyethylene glycol
  • the addition of polyethylene glycol (PEG) can reduce the risk of
  • the formation of nuclei in the RO water can be additionally reduced, whereby the long-term stability is further increased.
  • the filling of the cuvette with RO water also has the advantage that the refractive index between the transition from the cuvette to the absorption body of the absorption standard is matched to the calibration standard for the zero adjustment of the apparatus for detecting blood, which is also preferably with RO Water is filled, but does not contain the absorbent body.
  • a preferred embodiment of the stray standard provides a diffuser that is frosted or roughened on one side.
  • the scattering body may be, for example, a rectangular or round disc.
  • the disc is preferably a glass sheet.
  • the matting of the disc can be done by suitable processing methods.
  • the surface of the disc may be sandblasted or etched.
  • the frosted side of the disc can be provided with a seal of a transparent lacquer or a transparent coating, so that the optical properties can not change by a liquid, in which the disc can be introduced.
  • the coating is preferably a layer of epoxy resin.
  • a particularly preferred embodiment of the stray standard which is characterized by an improved measuring effect, provides that the straightening standard has a diffuser having two discs, of which one disc is matted or roughened on one side, whereby both discs are arranged on top of each other, that the frosted or roughened side of the one disc lies inside.
  • An alternative particularly preferred embodiment provides a diffuser having two discs, which are frosted or roughened on one side, wherein both discs are arranged one above the other so that the frosted sides of the two discs are inside. The two discs can be glued together. Even in these embodiments, the frosted or roughened side of the one disc or the frosted or roughened sides of the two discs can not come in contact with a liquid.
  • the scattering standard can also have a scattering body made of a transparent potting compound in which scattering particles, in particular insoluble salts, polystyrene particles or gypsum, are embedded.
  • the scattering standard like the absorption standard, has one with a liquid,
  • the cuvette of the scattering standard like the cuvette of the absorption standard, is introduced into the beam path between the light emitter and the light receiver of the device for detecting blood.
  • the straightening standard comprises a cuvette filled with a liquid containing scattering particles.
  • the cuvette is preferably filled with lipids dissolved in a liquid.
  • the cuvette can be filled, for example, with the parenteral nutritional solutions of Fresenius Kabi AG known under the trade name Smoflipid or Intralipid.
  • a scattering body by introducing liquids containing a scattering particle into an intermediate space between two transparent panes, in particular glass panes, wherein the intermediate space is sealed to the outside.
  • This scattering body can in turn be introduced into the beam path of the device for detecting blood or blood constituents in a cuvette filled with a liquid, in particular dialysis fluid or RO water.
  • a beam deflection unit in particular a deflection mirror, is preferably arranged in the beam path between the light transmitter and the light receiver.
  • the deflection mirror can deflect the light by 45 ° so that the light can simply be coupled into a spectrometer.
  • the reflectance of the mirror should be in the relevant wavelength range of about 350 nm to 800 nm
  • the arrangement according to the invention is intended for calibrating devices for detecting blood or blood constituents in a liquid, which have a receptacle for a cuvette, which is designed such that a receptacle inserted into the receptacle Cuvette is arranged in the beam path between the light emitter and the light receiver.
  • the arrangement according to the invention comprises an absorption standard which can be inserted into the receptacle of the cuvette and which has optical properties predetermined in relation to the absorption of the light into blood, and an insertable into the receptacle of the cuvette
  • the arrangement comprises an evaluation unit for determining a characteristic properties of the device for detecting blood or blood component descriptive calibration record, which contains data for identifying the device for detecting blood or blood components.
  • the arrangement may also comprise a spectrometer for measuring the spectral distribution of the light of the light emitter of the device for detecting blood or blood constituents.
  • Fig. 1 is a simplified schematic representation of an apparatus for
  • extracorporeal blood treatment comprising a device for detecting blood or a blood component in the dialysis fluid,
  • Fig. 2 is a sectional view of the device for detecting blood or a
  • Fig. 3 is a sectional view of the device for detecting blood or a
  • 5 is a simplified representation of an absorption standard
  • 5A is a simplified illustration of a first embodiment of an absorption body of the absorption standard
  • 5B is a simplified representation of a second embodiment of a
  • 6A is a simplified representation of a first embodiment of a
  • 6B is a simplified representation of a second embodiment of a
  • Fig. 7 shows another embodiment of a stray normal in a simplified
  • FIG. 1 shows, in a highly simplified schematic representation, a device for extracorporeal blood treatment, for example a dialysis device.
  • Extracorporeal blood treatment device has a dialyzer or filter 1, which passes through a semipermeable membrane 2 into a blood chamber 3 and a
  • Dialysis fluid chamber 4 is divided. From the patient leads an arterial blood line 5 to the blood chamber 3, while from the blood chamber 3 a venous
  • Blood line 6 which leads to the patient.
  • An arranged in the arterial blood line 5 blood pump 7 promotes the blood in extracorporeal blood circulation I.
  • Dialysis fluid branch II of the dialysis machine is shown only schematically.
  • the Dialysier thoroughlykeitszweig II includes a leading to the dialysis fluid chamber 4 Dialysierckenkeitszuschreibtechnisch 8 and one of the
  • the blood treatment apparatus has a central control unit 10 with which the individual components, for example the blood pump 7, are controlled.
  • the blood treatment device has a device 11 for detecting blood or a blood component, in particular
  • Hemoglobin in the dialysis fluid.
  • Fig. 2 shows the essential components of the device 11 for detecting blood or a blood constituent.
  • the device has a housing body 12 with a receptacle 13 into which a cuvette 14 can be suitably inserted.
  • the receptacle 13 for the cuvette 14 has a first apertured diaphragm 15 and a second apertured diaphragm 16.
  • a light transmitter 17 is arranged in front of one of the two apertured diaphragms 16 and a light receiver 18 in front of the other apertured diaphragm 17 so that the beam path 19 passes through an apertured diaphragm 16. enters the cuvette 14, exits the cuvette, passes through the other pinhole 15 and strikes the light receiver 18.
  • the cuvette is part of the Dialysier deviskeitsabloomtechnisch 9, so that through the cuvette
  • the light emitter 17 for example a bi-color LED, alternately emits green light having a wavelength which is between 550 nm and 575 nm, preferably between 555 nm and 570 nm, particularly preferably between 560 nm and 565 nm, and red light or in near-infrared (NIR) light having a wavelength between 630 nm and 780 nm, preferably between 630 nm and 675 nm, more preferably between 640 nm and 660 nm.
  • the light receiver 18 generates a
  • an evaluation unit 20 is provided, which is shown only schematically in Fig. 2.
  • c is the concentration of the fluid
  • d is the inner diameter of the cuvette
  • the evaluation unit 20 receives the proportional to the intensity of the light
  • Wavelength range with each other On the basis of the comparison of the measured intensities of the light, it is concluded that blood or a blood component, in particular hemoglobin, enters the dialysis fluid. Characteristic limit values can be specified for the evaluation of the measuring signals. The evaluation can be carried out for example by a method which is described in DE 37 26 524 AI.
  • the evaluation unit 20 takes into account in one
  • Calibration record containing data which may include, for example, the spectral distribution of the light of the light emitter 17 or in the calibration determined correction factors.
  • the calibration data record is stored in a memory 20A of the evaluation unit 20.
  • the calibration dataset contains further data, for example a serial number or MAC address.
  • the calibration data record can be transmitted via a data line (not shown) into the memory 20A of the evaluation unit 20 of the device 11 for detecting blood or blood constituents can be read, so that the evaluation of the measured values for the detection of blood or blood components can be made on the basis of the calibration record.
  • the calibration data set can also be stored in the memory of a central storage device (server), not shown, from which the data is then stored in the
  • Evaluation unit 20 of the device 11 for detecting blood or blood components or a memory of the central control unit 10 of the blood treatment device can be read, so that the evaluation unit 20 can access the data.
  • prepared cuvettes are used, which are inserted into the receptacle 13 of the device 11 for the detection of blood or blood components in order to be able to carry out various measurements.
  • Calibration takes place in individual calibration zones, which are run through one after the other. The individual measurements are carried out in the calibration zones, the measured values being evaluated in the evaluation unit 21 of the calibration stand.
  • the spectrum of the light emitter 17 of the device 11 for detecting blood or blood components is measured, in particular the spectrum of the green and red light.
  • a cuvette instead of a cuvette, a
  • Beam deflection unit 22 fits into the receptacle 13 of the device 11 for detecting blood or blood components used.
  • FIG. 3 shows the device 11 for detecting blood or blood components together with the beam deflection unit 22.
  • the beam deflection unit 22 has a housing body 23 in which a
  • Deflection mirror 24 is arranged, which forms an angle of 45 ° with the beam path 19. Instead of a mirror but also a prism can be arranged in the beam path.
  • a pinhole 25 In the beam path 19 in front of the mirror 24 is a pinhole 25 and in one embodiment, behind the mirror, a cosine corrector 26, via which the light is coupled into a spectrometer 27, which via a data line 28A to the
  • Evaluation unit 22 is connected.
  • the spectral measurement serves to assess the position of the spectra in terms of the absorption of hemoglobin.
  • a NuU adjustment takes place on RO water, to which preferably PEG is admixed (1% PEG solution).
  • the intensity of the light of the light emitter 17 can also be measured.
  • a cuvette is in the beam path of the device for detecting blood or
  • Blood components between light emitter 17 and light receiver 18 used which is filled with RO water, so that the light of the light emitter can pass through the cuvette and impinge on the light receiver.
  • the output signal of the light receiver 18 is evaluated with the evaluation unit 21 of the calibration.
  • the evaluation unit receives the signal of the light receiver 18 via a data line 28B.
  • Fig. 4 shows a side view and top view of the cylindrical glass cuvette 29 for zero balance, which is sealed at the top and bottom with a closure member 29A, 29B.
  • Absorption standard can pass and impinge on the light receiver 18.
  • the output signal of the light receiver 18 is evaluated in the evaluation unit 21.
  • Fig. 5 shows the absorption standard 30, which has a cylindrical glass cuvette 31, which is sealed at the top and bottom with a closure part 31A, 31B.
  • the glass cuvette 31 is filled with RO water or a solution of RO water and PEG.
  • An absorption body 32 is arranged in the cuvette.
  • the two closure parts 31A, 31B are designed as a holder for the absorption body 32.
  • Fig. 5A shows a first embodiment of the absorbent body 32.
  • the absorbent body is a surface polished disc 33 of a potting compound containing the dye MACROLEX® Red Violet R in a homogeneous distribution.
  • the potting compound is polymethyl methacrylate (PMMA).
  • PMMA polymethyl methacrylate
  • FIG. 5B shows an alternative embodiment, in which the disk 33 is enclosed between two parallel glass plates 34, 35.
  • the scattering effect of blood is imitated with a stray normal, which is used instead of the absorption standard 30 in the receptacle 13 of the device 11 for detecting blood or blood constituents.
  • the output signal of the light receiver 18 is evaluated again with the evaluation unit 21.
  • Fig. 6 shows the stray normal 36, the one at the top and bottom with a
  • Closing part 37A, 37B tightly closed cylindrical glass cuvette 37, in which a scattering body 38 is arranged.
  • the two closure parts 37A, 37B are designed as a holder for the scattering body 38.
  • the cuvette 37 is filled with RO water or a solution of RO water and PEG.
  • Fig. 6A shows a first embodiment of the scattering body 38.
  • the scattering body 38 is a glass plate 39, which is frosted or roughened on one side 40.
  • FIG. 6B shows an alternative embodiment of the diffuser body 38 comprising two glass sheets 41, 42 which are glued together.
  • the two glass sheets 41, 42 are matted or roughened on the inner sides 41A, 42B. But it is also possible that the inside of only one of the two glass sheets is frosted or roughened.
  • the scattering body can also be made as the absorption body of a transparent potting compound, which are added instead of a dye scattering particles in a homogeneous distribution.
  • the scattering particles may be insoluble salts, polystyrene particles, titanium dioxide or gypsum.
  • FIG. 7 shows an embodiment of a straightening standard 43, which contains a scattering liquid 44 instead of a scattering body.
  • the scattering liquid is, for example, a lipid-containing solution.
  • lipid-containing solution for example, those under the trade name
  • the straightening standard 44 has a cuvette 45, which is filled with the scattering liquid 44.

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Water Supply & Treatment (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Mathematical Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
EP18710329.6A 2017-02-16 2018-02-15 Verfahren und anordnung zum kalibrieren von vorrichtungen zur erkennung von blut oder blutbestandteilen in einer flüssigkeit Withdrawn EP3583404A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102017001484.1A DE102017001484A1 (de) 2017-02-16 2017-02-16 Verfahren und Anordnung zum Kalibrieren von Vorrichtungen zur Erkennung von Blut oder Blutbestandteilen in einer Flüssigkeit
PCT/EP2018/053797 WO2018149921A1 (de) 2017-02-16 2018-02-15 Verfahren und anordnung zum kalibrieren von vorrichtungen zur erkennung von blut oder blutbestandteilen in einer flüssigkeit

Publications (1)

Publication Number Publication Date
EP3583404A1 true EP3583404A1 (de) 2019-12-25

Family

ID=61622502

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18710329.6A Withdrawn EP3583404A1 (de) 2017-02-16 2018-02-15 Verfahren und anordnung zum kalibrieren von vorrichtungen zur erkennung von blut oder blutbestandteilen in einer flüssigkeit

Country Status (6)

Country Link
US (1) US10987459B2 (https=)
EP (1) EP3583404A1 (https=)
JP (1) JP7203739B2 (https=)
CN (1) CN110300885B (https=)
DE (1) DE102017001484A1 (https=)
WO (1) WO2018149921A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102019103028A1 (de) * 2019-02-07 2020-08-13 Fresenius Medical Care Deutschland Gmbh Simulationsmodell zur Simulation einer Schlauchleitung für einen Blutleckdetektor sowie Verfahren zum Testen eines Blutleckdetektors
WO2022026455A1 (en) * 2020-07-27 2022-02-03 Custom Sensors & Technology Flow cell for fiber optic spectrometers and photometers
EP4368219A1 (en) * 2022-11-08 2024-05-15 Haermonics BV System for flushing a wound and/or a body cavity, in particular the pericardial cavity
EP4698891A1 (en) * 2023-04-20 2026-02-25 Worcester Polytechnic Institute Opacity testing through measured illuminance
DE102023127655A1 (de) * 2023-10-10 2025-04-10 Digitaler Ernährungskompass GmbH Vorrichtung zur Bestimmung mindestens einer optischen Eigenschaft einer Probe in einer Küvette, sowie LED zur Verwendung in der Vorrichtung, sowie optisches Verfahren zur Bestimmung mindestens einer Eigenschaft einer Probe in einer Küvette mit einer Vorrichtung
DE102023134140A1 (de) 2023-12-06 2025-06-12 B.Braun Avitum Ag Detektionseinrichtung zur Detektion von Blut in einer Flüssigkeit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160370285A1 (en) * 2015-06-19 2016-12-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv Solid hemoglobin-polymer biophotonic phantoms and their use

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764646A (en) * 1966-02-10 1973-10-09 Hach Chemical Co Method of making comparator color wheels
US3512895A (en) * 1967-02-06 1970-05-19 Eastman Kodak Co Spectroreflectrometric reference standard and method
US3565535A (en) * 1968-10-14 1971-02-23 Calbiochem Linear densitometer
US4370983A (en) * 1971-01-20 1983-02-01 Lichtenstein Eric Stefan Computer-control medical care system
JPS5911864B2 (ja) * 1975-07-14 1984-03-19 武田薬品工業株式会社 漏血検知装置
JPS5428681A (en) * 1977-08-05 1979-03-03 Minolta Camera Co Ltd Blood detecting apparatus in blood dialysis
US4417355A (en) * 1981-01-08 1983-11-22 Leningradskoe Npo "Burevestnik" X-Ray fluorescence spectrometer
DE3423922A1 (de) * 1984-06-29 1986-01-09 Hartmann & Braun Ag, 6000 Frankfurt Fotometer zur kontinuierlichen analyse mehrerer komponenten eines fluessigen oder gasfoermigen mediums
DE3535652A1 (de) * 1984-11-01 1986-04-30 Jenoptik Jena Gmbh, Ddr 6900 Jena Anordnung zur optischen strahlenfuehrung in photometrischen analysenmessgeraeten
US4835110A (en) * 1985-12-23 1989-05-30 Beckman Instruments, Inc. Method for enhancing analysis timing in kinetic nephelometry
DE3726524A1 (de) 1987-08-10 1989-02-23 Fresenius Ag Haemoglobindetektor
DE3811475A1 (de) * 1988-04-06 1989-10-19 Deutsche Forsch Luft Raumfahrt Messeinrichtung zur bestimmung des streu- und absorptionskoeffizienten der atmosphaere
US5354725A (en) * 1991-11-29 1994-10-11 Dai Nippon Printing Co., Ltd. Medical image forming method, forming apparatus of the same, and thermal transfer sheet of the same
DK88893D0 (da) * 1993-07-30 1993-07-30 Radiometer As A method and an apparatus for determining the content of a constituent of blood of an individual
JP2590688Y2 (ja) * 1993-10-21 1999-02-17 株式会社島津製作所 血液凝固分析装置
FI935180A0 (fi) * 1993-11-22 1993-11-22 Rautaruukki Oy Konstruktion hos ett kalibreringsstycke, foerfarande foer utforming av den samma och kalibreringsfoerfarande
US5601080A (en) * 1994-12-28 1997-02-11 Coretech Medical Technologies Corporation Spectrophotometric blood analysis
US5591344A (en) 1995-02-13 1997-01-07 Aksys, Ltd. Hot water disinfection of dialysis machines, including the extracorporeal circuit thereof
GB9612264D0 (en) * 1996-06-12 1996-08-14 Samsoondar James Quality control material for monitoring calibration of instruments designed to measure serum and plasma specimen integrity
US5741441A (en) * 1996-07-03 1998-04-21 Beckman Instruments, Inc. Non-liquid scatter standard
US6117099A (en) * 1996-10-23 2000-09-12 In-Line Diagnostics Corporation System and method for noninvasive hemodynamic measurements in hemodialysis shunts
US5963335A (en) * 1997-06-25 1999-10-05 Waters Instruments, Inc. Means and method for measuring absorption of radiation-scattering samples
US6064474A (en) * 1998-02-06 2000-05-16 Optical Sensors, Inc. Optical measurement of blood hematocrit incorporating a self-calibration algorithm
US6174728B1 (en) * 1998-04-03 2001-01-16 Avl Medical Instruments Ag Control or calibration standard for use with instruments for optical measurement of hemoglobin concentration in blood samples
JP2000292344A (ja) * 1999-02-02 2000-10-20 Kubota Corp 光通路形成装置
DE19922812C2 (de) * 1999-05-19 2001-10-25 Merck Patent Gmbh Messung von Trübungen mittels Reflektometrie
US6470279B1 (en) * 1999-11-23 2002-10-22 James Samsoondar Method for calibrating spectrophotometric apparatus with synthetic fluids to measure plasma and serum analytes
DE10213692B4 (de) * 2002-03-27 2013-05-23 Weinmann Diagnostics Gmbh & Co. Kg Verfahren zur Steuerung einer Vorrichtung und Vorrichtung zur Messung von Inhaltsstoffen im Blut
EP1418417A3 (en) * 2002-09-30 2004-09-08 Spectromedical Inc. Method for calibrating spectrophotometric apparatus
US7169303B2 (en) * 2003-05-28 2007-01-30 Hemocleanse Technologies, Llc Sorbent reactor for extracorporeal blood treatment systems, peritoneal dialysis systems, and other body fluid treatment systems
CA2527667C (en) * 2003-07-02 2013-03-12 Gambro, Inc. Monitoring and control system for blood processing
US7236812B1 (en) * 2003-09-02 2007-06-26 Biotex, Inc. System, device and method for determining the concentration of an analyte
US7061608B2 (en) * 2004-01-30 2006-06-13 Artel, Inc. Apparatus and method for calibration of spectrophotometers
DE102004006238A1 (de) * 2004-02-09 2005-08-25 IER Meß- und Regeltechnik Eberhard Henkel GmbH Kalibriervorrichtung und -verfahren für Trübungsmessgerät
DE502004009975D1 (de) * 2004-11-17 2009-10-08 Pulsion Medical Sys Ag Kalibrierreflektorvorrichtung und damit ausgestattete Sondenanordnung
JP4919003B2 (ja) * 2006-05-31 2012-04-18 横河電機株式会社 濁度測定器
US10463774B2 (en) * 2007-02-27 2019-11-05 Deka Products Limited Partnership Control systems and methods for blood or fluid handling medical devices
US8535522B2 (en) * 2009-02-12 2013-09-17 Fresenius Medical Care Holdings, Inc. System and method for detection of disconnection in an extracorporeal blood circuit
EP2233913B1 (de) * 2009-03-24 2017-07-19 BAM Bundesanstalt für Materialforschung und -prüfung Optischer Standard zur Kalibrierung und Charakterisierung von optischen Messeinrichtungen
JP6027720B2 (ja) * 2009-12-14 2016-11-16 日機装株式会社 血液浄化装置
DE102010034553A1 (de) * 2010-08-17 2012-03-08 Fresenius Medical Care Deutschland Gmbh Vorrichtung zur Ermittlung und/oder Überwachung von Fremdstrukturen in einem Fluid oder einem Fluidstrom sowie Verfahren hierzu
US9194792B2 (en) * 2010-09-07 2015-11-24 Fresenius Medical Care Holdings, Inc. Blood chamber for an optical blood monitoring system
JP2012071036A (ja) * 2010-09-29 2012-04-12 Terumo Corp 血液成分測定装置を較正するための較正用構造体及びその較正方法
WO2012068416A1 (en) * 2010-11-17 2012-05-24 Fresenius Medical Care Holdings, Inc. Sensor clip assembly for an optical monitoring system
EP2510958B2 (en) * 2011-04-11 2023-02-15 Fresenius Medical Care Deutschland GmbH Method and apparatus for monitoring a treatment of a patient, preferably for monitoring hemodialysis, hemodiafiltration and/or peritoneal dialysis
DE102011087679B3 (de) * 2011-12-02 2013-04-18 Schildtec GmbH Meßkammer für einen optisch arbeitenden Sensor zum Bestimmen einer Konzentration eines Stoffes
JP5984290B2 (ja) * 2012-07-20 2016-09-06 株式会社日立ハイテクノロジーズ 自動分析装置
DE202013011936U1 (de) 2013-06-27 2014-11-17 Fresenius Medical Care Deutschland Gmbh Vorrichtung zur Erkennung von Blut oder eines Blutbestandteils in einer Flüssigkeit
US9308306B2 (en) * 2014-02-24 2016-04-12 Fresenius Medical Care Holdings, Inc. Self calibrating blood chamber
US10323178B2 (en) * 2014-05-16 2019-06-18 The University Of Connecticut Color tuning of electrochromic devices using an organic dye
US10151630B2 (en) * 2016-02-04 2018-12-11 Nova Biomedical Corporation Analyte system and method for determining hemoglobin parameters in whole blood
US10739253B2 (en) * 2016-06-07 2020-08-11 Youv Labs, Inc. Methods, systems, and devices for calibrating light sensing devices

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160370285A1 (en) * 2015-06-19 2016-12-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv Solid hemoglobin-polymer biophotonic phantoms and their use

Also Published As

Publication number Publication date
DE102017001484A1 (de) 2018-08-16
WO2018149921A1 (de) 2018-08-23
JP2020509361A (ja) 2020-03-26
CN110300885A (zh) 2019-10-01
US10987459B2 (en) 2021-04-27
CN110300885B (zh) 2022-08-02
US20190388601A1 (en) 2019-12-26
JP7203739B2 (ja) 2023-01-13

Similar Documents

Publication Publication Date Title
EP3583404A1 (de) Verfahren und anordnung zum kalibrieren von vorrichtungen zur erkennung von blut oder blutbestandteilen in einer flüssigkeit
DE69418546T2 (de) Vorrichtung und Verfahren zur Messung der Konzentration von Glukose mittels Lichtstreuung
EP2032967B1 (de) Spektroskopischer detektor und verfahren zur bestimmung von blut und biologischen markersubstanzen in flüssigkeiten
DE2851138C2 (https=)
DE3876321T2 (de) Kopf zur messung des reflexionsvermoegens von entfernten proben.
DE3103476C2 (https=)
AT404513B (de) Verfahren und messanordnung zur optischen bestimmung der totalen hämoglobinkonzentration
DE2049716C3 (de) Verfahren und Vorrichtung zur Absorptionsmessung im Blut
EP3759472B1 (de) Verfahren zur messung der permeabilität von superabsorbern
DE60312737T2 (de) Verfahren und Vorrichtung zur Messung von Blutbestandteilen
EP2710348B1 (de) Verfahren und system zum bestimmen der konzentration von substanzen in körperflüssigkeiten
DE102010034626A1 (de) Vorrichtung zur extrakorporalen Blutbehandlung
DE2340252A1 (de) Verfahren und einrichtung zur auszaehlung von biologischen partikeln
DE2000931A1 (de) Verfahren und Geraet zur Messung von Bilirubin in Blutserum
DE102016116100A1 (de) Erfassungsvorrichtung für ein Medium in einem Schlauchabschnitt
DE2339438A1 (de) Verfahren und vorrichtung zur spektralanalyse von emulsionen und suspensionen
EP0807813B1 (de) Vorrichtung für die Messung physiologischer Parameter von in einem extrakorporalen Kreislauf geführtem Blut
EP1054252B1 (de) Optische Messanordnung zur Bestimmung der Transmissions- und Streustrahlung
DE2461422A1 (de) Automatische chemische pruefvorrichtung
EP2590562A2 (de) Bestimmen der konzentration eines blutbestandteils in einer schlauchleitung
DE69636211T2 (de) Verfahren für die optische Messung einer Flüssigkeit in einem porösen Material
DE102009005402B4 (de) Verfahren zum Bestimmen der Konzentration von Blutbestandteilen in einer mit Blut gefüllten Schlauchleitung
EP3591378A1 (de) Verfahren zur bestimmung von lipiden, hämoglobin und bilirubin in körperflüssigkeitsproben
DE102020104266B3 (de) Vorrichtung und Methode zur Analyse von Blut
DE60320355T2 (de) Lesekopf für diffuse Reflektion

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190807

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210602

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20250902